However, somatic mutations in the ncPRC1 subunit BCOR have been identified in AML and myelodysplastic syndrome, and mouse studies support a tumor suppressor function in leukemia (Damm et al. 2013; Tanaka et al. 2017; Kelly et al. 2019). Here, BCOR is linked to neoplasm.